✨ Free AI Report
Acura Pharmaceuticals, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Acura Pharmaceuticals, Inc.
Research Preview

Acura Pharmaceuticals, Inc.: Business Overview, Financials & Competitive Analysis

Acura Pharmaceuticals is an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended to address safe use of medications. The company offers Oxay...

Analyst-debate audio for Acura Pharmaceuticals, Inc.

AskCyborg analysts argue the bull and bear cases for Acura Pharmaceuticals, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Acura Pharmaceuticals, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
4/ 10Mixed

Cyborg Score thesis

Niche specialty pharma with relevant abuse-deterrent technologies but constrained by partnership dependency and small operational...

Read the full analyst-debate transcript →
Industry Pharmaceutical Manufacturing / Drug Delivery
3 named competitors
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: July 6, 2026
AI-Verified Research
30+ Page Report

Get the Latest Acura Pharmaceuticals, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Acura Pharmaceuticals, Inc. Overview

Pro stress-test →

Acura Pharmaceuticals is an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended to address safe use of medications. The company offers Oxaydo tablets for moderate to severe pain management and Nexafed products used as nasal decongestants in cold and allergy products.

Strategic Profile

Pro stress-test →

The company is a specialty pharmaceutical company engaged in addressing medication abuse and misuse through three proprietary technology platforms. Acura has licensed its technologies to partners including Abuse Deterrent Pharmaceuticals LLC, Zyla Life Sciences, and MainPointe Pharmaceuticals LLC for commercial development.

Competitive Landscape

Pro stress-test →

Acura operates in the specialized abuse-deterrent pharmaceutical market, competing with larger pharmaceutical companies and drug delivery innovators developing similar technologies. The company's competitive advantage lies in its patented platform technologies rather than market share or distribution breadth. Main competitors include major pharmaceutical firms with abuse-deterrent opioid programs.

Industry Context

Acura Pharmaceuticals, Inc. operates in Pharmaceutical Manufacturing / Drug Delivery.

Key facts

Founded: 1935 · Headquarters: Palatine, Illinois, USA · Employees: 11-50 · Revenue: $1.56M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Acura Pharmaceuticals, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

DuragesicFentanyl patch with abuse-deterrent formulation→OxyContinExtended-release oxycodone with tamper-resistant formulation→MorphabondExtended-release morphine with abuse-deterrent features→

Compare Acura Pharmaceuticals, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Acura Pharmaceuticals, Inc. operates in Pharmaceutical Manufacturing / Drug Delivery. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical Manufacturing / Drug Delivery research →
NEW · MCP server

Ask your AI assistant about Acura Pharmaceuticals, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Acura Pharmaceuticals, Inc. and its top competitor on Cyborg Score”
“What did Acura Pharmaceuticals, Inc. do this quarter?”
“Is Acura Pharmaceuticals, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Acura Pharmaceuticals, Inc. do?+
Acura Pharmaceuticals is an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended to address safe use of medications. The company offers Oxay...
What is Acura Pharmaceuticals, Inc.'s Cyborg Score?+
Acura Pharmaceuticals, Inc. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Acura Pharmaceuticals, Inc.'s main competitors?+
Named competitors include Duragesic, OxyContin, Morphabond. The full competitive landscape is in the AskCyborg report.
How can I get the full Acura Pharmaceuticals, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Acura Pharmaceuticals, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Acura Pharmaceuticals, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9GELEX Group Joint Stock Company9TTM Technologies, Inc.9Insulet Corporation9Marathon Petroleum Corporation9Seagate Technology Holdings plc9Howmet Aerospace Inc.9Investor AB9Micron Technology, Inc.9Taiwan Semiconductor Manufacturing Company Limited9NVIDIA Corporation8NIO Inc.8Seanergy Maritime Holdings Corp.8Grupo Aeroméxico, S.A.B. de C.V.8Gulf Medical Projects Company8Interloop Limited8Kyverna Therapeutics, Inc.8Tatton Asset Management Plc8Invictus Investment Company PLC